Interstitium Discovery Reshapes Cancer and Pain Research
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Neil Theise at NYU's 2018 study used a laser-endoscope to image living tissue, revealing that the interstitium is a body-wide interconnected network rather than isolated compartments around each organ — a finding impossible to see before because standard biopsies drain the fluid and collapse the collagen scaffolding.
- Interstitial fluid comprises roughly 12 percent of body weight and contains hyaluronic acid, collagen, and elastin scaffolding, with flow driven by high-pressure arteries, muscular squeezing, digestive peristalsis, and arterial pulsing.
- David Lyden at Weill Cornell Medical College discovered in 2015 that tumour cells launch extracellular vesicles carrying chemical "addresses" through the interstitium, preparing distant organs for metastasis by promoting blood-vessel growth before cancer cells themselves arrive.
- Melody Swartz at the University of Chicago is developing a vaccine that induces lymphatic vessel growth around melanomas to attract cancer-killing T-cells; mouse tests suggest the approach can limit the disease's spread.
- Telocytes, first named in 2010 by Laurentiu Popescu and Maria-Simonetta Faussone-Pellegrini, create synapse-like junctions with all body cell types and may be the source of much proprioception and muscle pain.
- Rebecca Wells at the University of Pennsylvania noted that recognizing the interstitial location of necrotising fasciitis and cellulitis may reveal how those fast-moving infections spread through tissue.
- Tattoo-ink biopsies provided visible proof of interconnection: ink injected into skin crept into interstitial spaces around other organs, demonstrating that compartments throughout the body link up.
Why it matters: Lyden's research identifies a concrete therapeutic target — chemically addressed tumour vesicles that prepare distant organs for metastasis — with the stated goal of personalised treatments that deliver payloads to specific tissues and spare healthy ones. For chronic pain patients, the recognition that telocytes and interstitial proprioception may underlie muscle stiffness reframes conditions current treatments cannot explain. Both lines remain early-stage but rest on an anatomical model that did not exist before the 2018 study.
Ask SkimNews
